Literature DB >> 7071810

Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.

D H Namm, A S Tadepalli, J A High.   

Abstract

A semi-synthetic 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine (alkylacetyl-GPC) was shown to be highly species selective in its capacity to cause platelet aggregation and serotonin release. No effects were elicited on the rat or mouse platelets while platelets from human, dog, cat, rabbit, guinea pig and horse were highly sensitive to alkylacetyl-GPC. The hypotensive activity in the rat was not associated with thrombocytopenia. Preliminary evidence suggested that the inability of platelets of the rat and mouse to respond to alkylacetyl-GPC was not due to a difference in plasma inactivation of the substance but due to a difference in platelet responsiveness per se. The data also support the concept that the potent hypotensive property of this substance readily observed in the rat, is a result of an effect which is platelet-independent.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071810     DOI: 10.1016/0049-3848(82)90234-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  11 in total

1.  Biological response of guinea pig peritoneal macrophages to platelet-activating factor.

Authors:  H Hayashi; I Kudo; S Nojima; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist.

Authors:  T Yamada; M Saito; T Mase; H Hara; H Nagaoka; K Murase; K Tomioka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Platelet and Erythrocyte Sources of S1P Are Redundant for Vascular Development and Homeostasis, but Both Rendered Essential After Plasma S1P Depletion in Anaphylactic Shock.

Authors:  Salomé L Gazit; Boubacar Mariko; Patrice Thérond; Benoit Decouture; Yuquan Xiong; Ludovic Couty; Philippe Bonnin; Véronique Baudrie; Sylvain M Le Gall; Blandine Dizier; Nesrine Zoghdani; Jessica Ransinan; Justin R Hamilton; Pascale Gaussem; Pierre-Louis Tharaux; Jerold Chun; Shaun R Coughlin; Christilla Bachelot-Loza; Timothy Hla; Benoit Ho-Tin-Noé; Eric Camerer
Journal:  Circ Res       Date:  2016-08-31       Impact factor: 17.367

4.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

5.  Protection of platelet-activating factor-induced acute renal failure by BN 52021.

Authors:  E Pirotzky; P Colliez; C Guilmard; J Schaeverbeke; J M Mencia-Huerta; P Braquet
Journal:  Br J Exp Pathol       Date:  1988-04

6.  Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.

Authors:  W M Hu; P C Choy; R Y Man
Journal:  Lipids       Date:  1991-09       Impact factor: 1.880

7.  Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

8.  In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.

Authors:  D Kelefiotis; C Vakirtzi-Lemonias
Journal:  Agents Actions       Date:  1993-11

9.  Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues.

Authors:  S E Burke; A M Lefer; K C Nicolaou; G M Smith; J B Smith
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

10.  Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice.

Authors:  M Criscuoli; A Subissi
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.